Cargando…
The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice
Tacrolimus (Tac) is a calcineurin inhibitor commonly used as an immunosuppressor after solid organ transplantation. However, Tac may induce hypertension, nephrotoxicity, and an increase in aldosterone levels. The activation of the mineralocorticoid receptor (MR) is related to the proinflammatory sta...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223994/ https://www.ncbi.nlm.nih.gov/pubmed/37242615 http://dx.doi.org/10.3390/pharmaceutics15051373 |
_version_ | 1785050071888297984 |
---|---|
author | Figueroa, Stefanny M. Bertocchio, Jean-Philippe Nakamura, Toshifumi El-Moghrabi, Soumaya Jaisser, Frédéric Amador, Cristián A. |
author_facet | Figueroa, Stefanny M. Bertocchio, Jean-Philippe Nakamura, Toshifumi El-Moghrabi, Soumaya Jaisser, Frédéric Amador, Cristián A. |
author_sort | Figueroa, Stefanny M. |
collection | PubMed |
description | Tacrolimus (Tac) is a calcineurin inhibitor commonly used as an immunosuppressor after solid organ transplantation. However, Tac may induce hypertension, nephrotoxicity, and an increase in aldosterone levels. The activation of the mineralocorticoid receptor (MR) is related to the proinflammatory status at the renal level. It modulates the vasoactive response as they are expressed on vascular smooth muscle cells (SMC). In this study, we investigated whether MR is involved in the renal damage generated by Tac and if the MR expressed in SMC is involved. Littermate control mice and mice with targeted deletion of the MR in SMC (SMC-MR-KO) were administered Tac (10 mg/Kg/d) for 10 days. Tac increased the blood pressure, plasma creatinine, expression of the renal induction of the interleukin (IL)-6 mRNA, and expression of neutrophil gelatinase-associated lipocalin (NGAL) protein, a marker of tubular damage (p < 0.05). Our study revealed that co-administration of spironolactone, an MR antagonist, or the absence of MR in SMC-MR-KO mice mitigated most of the unwanted effects of Tac. These results enhance our understanding of the involvement of MR in SMC during the adverse reactions of Tac treatment. Our findings provided an opportunity to design future studies considering the MR antagonism in transplanted subjects. |
format | Online Article Text |
id | pubmed-10223994 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102239942023-05-28 The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice Figueroa, Stefanny M. Bertocchio, Jean-Philippe Nakamura, Toshifumi El-Moghrabi, Soumaya Jaisser, Frédéric Amador, Cristián A. Pharmaceutics Communication Tacrolimus (Tac) is a calcineurin inhibitor commonly used as an immunosuppressor after solid organ transplantation. However, Tac may induce hypertension, nephrotoxicity, and an increase in aldosterone levels. The activation of the mineralocorticoid receptor (MR) is related to the proinflammatory status at the renal level. It modulates the vasoactive response as they are expressed on vascular smooth muscle cells (SMC). In this study, we investigated whether MR is involved in the renal damage generated by Tac and if the MR expressed in SMC is involved. Littermate control mice and mice with targeted deletion of the MR in SMC (SMC-MR-KO) were administered Tac (10 mg/Kg/d) for 10 days. Tac increased the blood pressure, plasma creatinine, expression of the renal induction of the interleukin (IL)-6 mRNA, and expression of neutrophil gelatinase-associated lipocalin (NGAL) protein, a marker of tubular damage (p < 0.05). Our study revealed that co-administration of spironolactone, an MR antagonist, or the absence of MR in SMC-MR-KO mice mitigated most of the unwanted effects of Tac. These results enhance our understanding of the involvement of MR in SMC during the adverse reactions of Tac treatment. Our findings provided an opportunity to design future studies considering the MR antagonism in transplanted subjects. MDPI 2023-04-29 /pmc/articles/PMC10223994/ /pubmed/37242615 http://dx.doi.org/10.3390/pharmaceutics15051373 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Figueroa, Stefanny M. Bertocchio, Jean-Philippe Nakamura, Toshifumi El-Moghrabi, Soumaya Jaisser, Frédéric Amador, Cristián A. The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title | The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title_full | The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title_fullStr | The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title_full_unstemmed | The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title_short | The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice |
title_sort | mineralocorticoid receptor on smooth muscle cells promotes tacrolimus-induced renal injury in mice |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223994/ https://www.ncbi.nlm.nih.gov/pubmed/37242615 http://dx.doi.org/10.3390/pharmaceutics15051373 |
work_keys_str_mv | AT figueroastefannym themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT bertocchiojeanphilippe themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT nakamuratoshifumi themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT elmoghrabisoumaya themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT jaisserfrederic themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT amadorcristiana themineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT figueroastefannym mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT bertocchiojeanphilippe mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT nakamuratoshifumi mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT elmoghrabisoumaya mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT jaisserfrederic mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice AT amadorcristiana mineralocorticoidreceptoronsmoothmusclecellspromotestacrolimusinducedrenalinjuryinmice |